Archives
-
Phosphatase Inhibition and Hippo Signaling Evidence
2026-10-14
Phosphatase inhibitors can help preserve phosphorylation measurements, but product claims should not be conflated with evidence for RNF166–angiomotin regulation in colorectal cancer.
-
Ion-Chelating Nanostructures and Tumour Immunity
2026-10-13
A source-grounded overview of Tan et al.’s study on metal-ion-chelating l-phenylalanine nanostructures, dendritic-cell activation, short-term starvation and immune checkpoint blockade, with attention to evidence strength and translational limits.
-
What ROS Assays Really Measure
2026-10-13
Miwa and colleagues report that carboxylesterase activity can convert Amplex Red to resorufin without hydrogen peroxide, challenging a common assumption in mitochondrial ROS measurement. The finding is directly relevant to interpreting oxidative-stress data, but it does not establish that the same interference affects WST-1-based SOD activity assays.
-
Cy5 NHS ester(Et): Identity and Evidence Scope
2026-10-12
Cy5 NHS ester(Et) is identified in APExBIO product documentation as a Cy5-based NHS-ester fluorescent dye intended for conceptual labeling of primary amines in proteins, peptides, and related biomolecules. No matched research paper was available, so application claims should be treated as supplier-described scope rather than independently validated performance evidence.
-
TAK-242 and Posttraumatic Epilepsy: Evidence Limits
2026-10-12
A source-grounded overview of Resatorvid research in a mouse model of posttraumatic epileptogenesis, emphasizing reported outcomes, mechanistic interpretation, evidence strength, and translational limitations.
-
JQ1, BRD4 and Ferroptosis: Evidence and Limits
2026-10-11
A source-grounded overview of how the 2025 Cell Death and Disease study links JQ1-mediated BET inhibition to TXNIP, histone H4 UFMylation, c-MYC chromatin activity and ferroptosis sensitivity, with emphasis on preclinical evidence boundaries and target-specificity limitations.
-
PDHA1 Succinylation in Cholangiocarcinoma
2026-10-10
A 2025 Nature Communications study links PDHA1 lysine-83 succinylation to alpha-ketoglutarate accumulation, impaired macrophage antigen presentation, and cholangiocarcinoma progression. The findings support a preclinical model in which targeting tumor metabolism may improve gemcitabine–cisplatin responses, while leaving important questions about specificity, clinical translation, and patient applicability.
-
Sulfisomidine in Pertussis: Evidence and Limits
2026-10-09
The 1956 report on Sulfisomidine in pertussis is notable for combining clinical observation with blood, urine, and safety measurements in a vulnerable pediatric series. It reported no deaths and detectable systemic exposure, but its uncontrolled design and concurrent pertussis-serum treatment limit conclusions about efficacy or present-day clinical use.
-
Cy7 NHS Ester Product Overview
2026-10-09
Cy7 NHS ester (SKU A8109), supplied by APExBIO, is described as a sulfonated near-infrared fluorescent reagent for conceptual amino-group labeling of proteins, peptides, and other biomolecules. No matched paper evidence was provided, so performance and application claims remain supplier-reported.
-
Sulfo-Cy3 NHS Ester in Vascular Biology Context
2026-10-08
This overview places Sulfo-Cy3 NHS ester within the broader context of vascular remodeling research while separating supplier-reported dye properties from findings in a 2025 Science Advances study. Zhu et al. reported that an AIBP–LRP2–HDL–miR-223 pathway restricts CXCR4-positive capillary endothelial expansion and collateral circulation in ischemic models. The dye may be conceptually relevant to observational protein-labeling and cell-biology assays, but the supplied study does not establish that Sulfo-Cy3 NHS ester was used or that the product validates the proposed mechanism. Human association, animal perturbation, molecular evidence, and translational applicability therefore require separate interpretation.
-
Metal-Chelating L-Phe Nanostructures Enhance ICB
2026-10-08
Tan and colleagues reported metal-ion-chelating L-phenylalanine nanostructures that remodel immunosuppressive tumour microenvironments by engaging dendritic-cell ion signaling, inflammasome activity and NF-κB pathways. In breast and colorectal tumour models, short-term starvation increased nanostructure uptake and strengthened tumour-specific cytotoxic T-cell responses, supporting further preclinical study alongside immune checkpoint blockade.
-
X-Gal and the Next Era of Translational Readouts
2026-10-07
X-Gal remains a powerful visual reporter for molecular cloning, but its greatest strategic value is as a clearly bounded readout within broader translational study designs. This article connects β-galactosidase reporting with new mechanistic evidence on iRhom2, ADAM17, olfactory receptors, and activity-dependent adaptation while defining what the evidence does—and does not—support.
-
P. vivax B-Cell Epitopes for Surveillance
2026-10-07
A 2026 study combined computational antigen prioritization, peptide serology, multiplex validation, and sequence conservation analysis to identify immunodominant Plasmodium vivax B-cell epitopes. Four candidates showed strong species-discriminating performance, while MSP9₃₈₄–₃₈₉ provided a signal associated with asymptomatic infection, supporting further evaluation for population-level surveillance rather than immediate standalone diagnosis.
-
Ferroelectric Photoreceptors for Adaptive Vision
2026-10-06
The reference study presents a ferroelectric–liquid metal hybrid artificial photoreceptor that combines broad-spectrum photoresponsivity with biomimetic visual adaptation. In rodent models of retinal degeneration, the implant restored sensitivity to visible light and extended detection into the infrared range, although longer-term and translational validation remain necessary.
-
Ademetionine in Methylation Research: Evidence and Limits
2026-10-06
A source-grounded overview of S-adenosylmethionine as a methyl-donor cofactor, using recent MaMT4 research in mulberry DNJ biosynthesis to distinguish biochemical findings from broader translational claims. The article compares evidence strength, conceptual applications, provenance, and limits across plant methylation research and CNS-related questions.